Back

The gut-heart axis: fecal microbiome shifts following SGLT2 inhibitor initiation in heart failure - a pilot study

11 May 2026 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: Frontiers in basic and translational heart failure research Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Miss Daniel Teshuva

Tel Aviv (Israel)

6 More presentations in this session

Presentation thumbnail
ACEI plus GLP1-RA or SGLT2i, as well as ARNI, exerted distinct protective effects against diabetic nephropathy and heart failure with preserved ejection fraction in eNOS-/- dbdb mice.
Doctor K. Yu (Nantong, CN)
Abstract Slides Video
Presentation thumbnail
Effects of sodium-glucose cotransporter 2 inhibitors on cardiac metabolism, assessed by phosphorus magnetic resonance spectroscopy, in patients with heart failure
Associate Professor P. Rubis (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
Epirubicin promotes coronary endothelial senescence and dysfunction with induction of pro-inflammatory and pro-thrombotic responses: role of the AT1R/NADPH oxidases/SGLT2 pro-oxidant pathway
Mr L. Axenbeck (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
The effect of ARNI and SGLT2i therapies on the inflammasome pathway in myocardial heart transplantation biobank samples.
Doctor D. Nagy (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Efficacy of interleukin-1 blockade for prevention of heart failure outcomes in patients with prior myocardial Infarction: a systematic review and meta-analysis of 10301 patients
Miss B. Tran (Debrecen, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Frontiers in basic and translational heart failure research

The Event

Event poster

Heart Failure 2026

11 May 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Gut microbiome: a hidden driver of inflammation in heart failure
thumbnail
Congress Presentation
Gut Microbiota and Associated Metabolites Play a Key Role in the Pathogenesis of the Obesity Phenotype of Heart Failure With Preserved Ejection Fraction
thumbnail
Congress Presentation
Oral microbiome alterations in heart failure: unveiling potential biomarkers and pathways for diagnosis and severity prediction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources